Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia
Status:
Completed
Trial end date:
2013-07-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of single doses of
PF-05089771 against placebo in treatment of pain in patients with primary, inherited
erythromelalgia.